Chandan Healthcare Ltd
Chandan Healthcare Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
The company is undergoing rapid expansion with many new diagnostic centers and labs opened in FY26 and plans for continued growth in FY27. For FY27, growth is expected to improve significantly due to expansion efforts, particularly new diagnostic centers and labs started last financial year now contributing (Page 23).
From Chandan Healthcare Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company is undergoing rapid expansion with many new diagnostic centers and labs opened in FY26 and plans for continued growth in FY27.
- They target opening 5 comprehensive centers and 20 standalone labs in FY27, covering all districts in Uttar Pradesh and Uttarakhand within two years before moving to other states.
- Franchise network plans to scale aggressively from 130+ to 1,000 operational franchises over the next 24 months.
- New initiatives like digital direct-to-consumer platforms, home sample collection, PET scans, and a genome lab are expected to drive growth.
- Growth from government PPP projects in Punjab, Haryana, and Assam (worth INR 800 crores over 10 years) will begin contributing from Q2 FY27.
2 more points from Chandan Healthcare Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Chandan Healthcare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- For FY27, Chandan Healthcare plans capital investment of INR 45-50 crores.
- This includes setting up 20 standalone labs (each costing ~INR 1 crore) and 5 comprehensive centers (each costing INR 6-7 crores).
- Comprehensive centers include pathology and full radiology services; standalone labs focus mainly on lab services.
- Funding for this capex will come from internal accruals and proceeds from warrants floated for INR 104 crores (25% already received).
- Expansion is focused on covering Uttar Pradesh and Uttarakhand districts in the next two years, with plans to proceed to other states afterward.
2 more points from Chandan Healthcare Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chandan Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The company has secured projects under the PPP model in Punjab, Haryana, and Assam with a combined estimated project value of INR 800 crores over 10 years.
- These projects were awarded in the last quarter and are currently under construction with machines being installed.
- The projects are expected to start gradually from Q2 of the financial year 2026-27, with all machines expected to be operational within the year.
- The management indicated that the revenue from these projects and other expansions will significantly boost the company's performance going forward.
Chandan Healthcare Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹65 Cr, net profit ₹5 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chandan Healthcare Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Invicta Diagnostic Ltd (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnos.'s Q4 FY26 earnings…
- KMC Speciality Hospitals (India) Ltd (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Gaudium IVF and Women Health Ltd (Q4 FY26)
Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…
- Apollo Hospitals Enterprise Ltd (Q4 FY26)
30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…
Arthneeti Pro · Annual
Chandan Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Chandan Healthcare Ltd Q4 FY26 results?
The company is undergoing rapid expansion with many new diagnostic centers and labs opened in FY26 and plans for continued growth in FY27. For FY27, growth is expected to improve significantly due to expansion efforts, particularly new diagnostic centers and labs started last financial year now contributing (Page 23).
What is Chandan Healthcare Ltd share price analysis?
Chandan Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 23.1 with a market cap of ₹606 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chandan Healthcare Ltd planning capital expenditure?
For FY27, Chandan Healthcare plans capital investment of INR 45-50 crores.
Keep Chandan Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.